Breakthrough trial aims to stop dangerous bleeding in emergency surgery
Disease control
Not yet recruiting
This study is testing whether a new drug called VMX-C001 can safely and effectively control bleeding during urgent, high-risk surgeries for patients taking common blood thinners (FXa DOACs). Researchers will compare the new drug to the usual standard of care in 800 participants. …
Phase: PHASE3 • Sponsor: VarmX B.V. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC